MET and hepatocellular carcinoma: In an additional analysis, we found that the patients with five positivities on Gα12, MDM2, c-Met, Zeb, and USP4 in HCC showed a significantly lower overall survival rate as compared to others, providing an insight into the contribution of the molecular network to HCC malignancy.